Report cover image

Prostate Specific Antigen Testing Market2026

Published Jan 23, 2026
Length 217 Pages
SKU # DTAM21127627

Description

Prostate Specific Antigen Testing Market Overview:
The Prostate Specific Antigen Testing Market was valued at in and is anticipated to reach by , at a CAGR of 0.04 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Prostate Specific Antigen Testing Market.

This report delivers a comprehensive overview of the Prostate Specific Antigen Testing Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prostate Specific Antigen Testing Market. The Prostate Specific Antigen Testing Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

Prostate Specific Antigen Testing Market Scope:
By Types
• Total Prostate Specific Antigen Test
• Complex Prostate-Specific Antigen Test
• Free Prostate-Specific Antigen Test
• Prostate-Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
• Trans-rectal Ultrasound
• Biopsy

By Application
• Screening
• Post-treating monitoring
• Others

By End User
• Hospitals
• Clinics
• Diagnostic Centers
• Research Institute
• Others

Major Highlights
This report delivers a comprehensive overview of the Prostate Specific Antigen Testing Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prostate Specific Antigen Testing Market. The Prostate Specific Antigen Testing Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

217 Pages
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Test Type
3.2. Market Snippet by Application
3.3. Market Snippet by Assay Type
3.4. Market Snippet by End User
3.5. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising prevalence of prostate cancer
4.1.1.2. Technological advancement
4.1.2. Restraints:
4.1.2.1. False positive or false negative PSA test results.
4.1.2.2. Development of alternative methods.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Types
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type Segment
7.1.2. Market Attractiveness Index, By Test Type Segment
7.2. Total Prostate Specific Antigen Test*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Complex Prostate-Specific Antigen Test
7.4. Free Prostate-Specific Antigen Test
7.5. Prostate-Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
7.6. Trans-rectal Ultrasound
7.7. Biopsy
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Screening*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Post-treating monitoring
8.4. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User Segment
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Clinics
9.4. Diagnostic Centers
9.5. Research Institute
9.6. Others
10. By Region
10.1. Introduction
10.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
10.3. Market Attractiveness Index, By Region
10.4. North America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay Type
10.4.6. Market Size Analysis ,and Y-o-Y Growth Analysis (%), By End User
10.4.6.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.2. U.S.
10.4.6.3. Canada
10.4.6.4. Mexico
10.5. Europe
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay Type
10.5.6. Market Size Analysis ,and Y-o-Y Growth Analysis (%), By End User
10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. Germany
10.5.7.2. U.K.
10.5.7.3. France
10.5.7.4. Italy
10.5.7.5. Spain
10.5.7.6. Rest of Europe
10.6. South America
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay Type
10.6.6. Market Size Analysis ,and Y-o-Y Growth Analysis (%), By End User
10.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.6.7.1. Brazil
10.6.7.2. Argentina
10.6.7.3. Rest of South America
10.7. Asia Pacific
10.7.1. Introduction
10.7.2. Key Region-Specific Dynamics
10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay Type
10.7.6. Market Size Analysis ,and Y-o-Y Growth Analysis (%), By End User
10.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.7.7.1. China
10.7.7.2. India
10.7.7.3. Japan
10.7.7.4. Australia
10.7.7.5. Rest of Asia Pacific
10.8. Middle East and Africa
10.8.1. Introduction
10.8.2. Key Region-Specific Dynamics
10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay Type
10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11. Global Prostate Specific Antigen Testing Market– By Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
12. Global Prostate Specific Antigen Testing Market– By Company Profiles
12.1. Cleveland Diagnostics*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Abbott
12.3. Siemens Healthcare
12.4. DiaSorin
12.5. Roche
12.6. Beckman Coulter
12.7. Mediwatch(LABORIE)
12.8. Bodi Tech
12.9. Bristol-Myers Squibb Company
12.10. GE Healthcare
12.11. Endocare
12.12. GlaxoSmith Kline
12.13. Anixa Biosciences
12.14. Ortho Clinical
12.15. Fujirebio
12.16. Pharmacia Delfia
12.17. Merck & Co(*LIST NOT EXHAUSTIVE)
13. DataM Intelligence
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.